University of California, San Francisco Logo

University of California, San Francisco | About UCSF | Search UCSF | UCSF Medical Center

Home > Treatment > Drug Dosing Toolkit > Trogarzo

ibalizumab (Trogarzo)

Type of Drug: Entry Inhibitor

Entry inhibitors work by stopping the HIV virus from getting into your body's healthy cells in the first place.

Approved adult dosing

800 mg

one intravenous (IV) infusion Trogarzo every 14 days (after initial IV loading dose of 2,000 mg)

  • Trogarzo


Notes on taking this medication

  • Trogarzo must be given by IV infusion, in a clinic or infusion center, every 14 days
  • Trogarzo is always prescribed in combination with other HIV medicines. The other HIV medicines are pills. You must take your HIV pills every day, including on the day you receive an IV infusion of Trogarzo.

Possible side effects

  • Nausea, diarrhea, dizziness, rash

See accompanying chart: Tips for Common Side Effects

My doctor's instructions

Scroll over drug name to see other names for the drug.